![](https://ellipse.prbb.org/wp-content/uploads/2024/05/Ana-M-Aldea-Ellipse-398x224.jpg)
Clinical trials
![](https://ellipse.prbb.org/wp-content/uploads/2024/05/Ana-M-Aldea-Ellipse-398x224.jpg)
![](https://ellipse.prbb.org/wp-content/uploads/2022/12/pavol-stugel-nV8BZqVqvpE-unsplash-3-398x224.jpg)
Treatment to improve cognitive function in Down’s syndrome on a clinical trial
![Iris L. Matilla Vaz es enfermera en la unidad de investigación clínica del IMIM, donde se realizan ensayos clínicos en fase I.](https://ellipse.prbb.org/wp-content/uploads/2021/05/P1030596_directe-LRC-a-jpg_11-2-398x224.jpeg)
Iris Lioba Matilla Vaz (IMIM): “Without clinical trials, medicine could not move forward”
![Several labs at the PRBB are joining forces to improve the lives of people with Sown Syndrome. Photo by Nathan Anderson on Unsplash](https://ellipse.prbb.org/wp-content/uploads/2021/03/nathan-anderson-zOjzAVjCTeI-unsplash-e1616426192552-398x224.jpg)
Down Syndrome research at the PRBB
![](https://ellipse.prbb.org/wp-content/uploads/2021/02/supl-398x224.jpg)
Launched a clinical trial to prevent the side effects of COVID-19
![](https://ellipse.prbb.org/wp-content/uploads/2021/02/Cargencors-398x224.jpg)
How do our genes influence our ability to overcome COVID-19?
![](https://ellipse.prbb.org/wp-content/uploads/2021/02/medicament-covid-398x224.jpg)
A clinical trial to verify the effectiveness of a new drug against COVID-19
![](https://ellipse.prbb.org/wp-content/uploads/2021/02/ECaBox-1-398x224.jpg)
Maria Pia Cosma (CRG): “We want to maintain donors’ eyes alive for one month”
![](https://ellipse.prbb.org/wp-content/uploads/2021/01/Ivermectina-398x224.jpg)
Ivermectin could reduce viral transmission of COVID-19
![](https://ellipse.prbb.org/wp-content/uploads/2021/01/Estudis-398x224.jpg)
Wanted: volunteers to contribute to scientific progress
![](https://ellipse.prbb.org/wp-content/uploads/2020/12/xchrom-398x224.jpg)
Public-private collaboration to develop a treatment for fragile X syndrome
![Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.](https://ellipse.prbb.org/wp-content/uploads/2020/05/SAINT-Project-noticia-Maig-14_2000x1125px-398x224.jpg)